Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity

v3.24.1.u1
Stockholders’ Equity
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Stockholders’ Equity

Note 10 – Stockholders’ Equity

 

Common Stock

 

For the three months ended March 31, 2024 and 2023, the Company sold 218,304 and 0, respectively, shares of its common stock under the ATM with BTIG, LLC.

 

Warrants

 

As of March 31, 2024, the Company did not have any outstanding warrants to purchase shares of the Company’s common stock.

 

Basic and diluted net loss per common share

 

During the three months ended March 31, 2024 and 2023, diluted loss per common share is the same as basic loss per common share because, as the Company incurred a net loss during each period presented, the potentially dilutive securities from the assumed exercise of all outstanding stock options and warrants, would have an anti-dilutive effect. The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have been anti-dilutive as of March 31, 2024 and 2023:

 

    As of March 31,  
    2024     2023  
Stock options     46,031,560       34,677,699  
Warrants     —       238,000  
Total     46,031,560       34,915,699